Towards gene therapy for EBV-associated posttransplant lymphoma with genetically modified EBV-specific cytotoxic T cells

Epstein-Barr virus (EBV)-associated posttransplant lymphoma (PTLD) is a major cause of morbidity/mortality after hematopoietic stem cell (SCT) or solid organ (SOT) transplant. Adoptive immunotherapy with EBV-specific cytotoxic lymphocytes (CTLs), although effective in SCT, is less successful after S...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ricciardelli, Ida, Blundell, Michael Patrick, Brewin, Jennifer, Thrasher, Adrian, Pule, Martin, Amrolia, Persis J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2014
Matèries:
Gene Therapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4199953/
https://ncbi.nlm.nih.gov/pubmed/25185261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-01-553362
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars